Advances in the biology and treatment of B-cell chronic lymphocytic leukemia, Blood, vol.85, pp.307-325, 1995. ,
Cell proliferation and death: Forgotten features of chronic lymphocytic leukemia B cells, Best Practice & Research Clinical Haematology, vol.20, issue.3, pp.399-413, 2007. ,
DOI : 10.1016/j.beha.2007.03.007
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells, Journal of Clinical Investigation, vol.115, issue.3, pp.755-64, 2005. ,
DOI : 10.1172/JCI23409DS1
Differential Effects on CLL Cell Survival Exerted by Different Microenvironmental Elements, Curr Top Microbiol Immunol, vol.294, pp.135-180, 2005. ,
DOI : 10.1007/3-540-29933-5_8
B-Cell Chronic Lymphocytic Leukemia: A Bird of a Different Feather, Journal of Clinical Oncology, vol.17, issue.1, pp.399-408, 1999. ,
DOI : 10.1200/JCO.1999.17.1.399
CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment, Blood, vol.111, issue.10, 2008. ,
DOI : 10.1182/blood-2007-08-108605
Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15, Embo J, vol.13, pp.2822-2852, 1994. ,
The Biology of Interleukin-2, Annual Review of Immunology, vol.26, issue.1, 2007. ,
DOI : 10.1146/annurev.immunol.26.021607.090357
Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function, Nature, vol.408, issue.10, pp.57-63, 2000. ,
Biology of the Interleukin-2 Receptor, Adv Immunol, vol.70, issue.11, pp.1-81, 1998. ,
DOI : 10.1016/S0065-2776(08)60386-7
The role of Stat5a and Stat5b in signaling by IL-2 family cytokines, Oncogene, vol.19, issue.21, pp.2566-76, 2000. ,
DOI : 10.1038/sj.onc.1203523
B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes, Blood, vol.99, issue.11, pp.4087-93, 2002. ,
DOI : 10.1182/blood.V99.11.4087
Immunostimulatory CpG-oligonucleotides induce functional high affinity IL-2 receptors on B-CLL cells, Experimental Hematology, vol.28, issue.5, pp.558-68, 2000. ,
DOI : 10.1016/S0301-472X(00)00144-2
Interleukin 10 (IL-10) upregulates functional high affinity IL-2 receptors on normal and leukemic B lymphocytes, Journal of Experimental Medicine, vol.178, issue.5, pp.1473-81, 1993. ,
DOI : 10.1084/jem.178.5.1473
Sensitization of IL-2 Signaling through TLR-7 Enhances B Lymphoma Cell Immunogenicity, The Journal of Immunology, vol.176, issue.6, pp.3830-3839, 2006. ,
DOI : 10.4049/jimmunol.176.6.3830
Cell cycle progression of chronic lymphocytic leukemia cells is controlled by cyclin D2, cyclin D3, cyclin-dependent kinase (cdk) 4 and the cdk inhibitor p27, Leukemia, vol.16, issue.3, pp.327-361, 2002. ,
DOI : 10.1038/sj.leu.2402389
Direct Cellular Interaction with Activated CD4+T Cells Overcomes Hyporesponsiveness of B-Cell Chronic Lymphocytic Leukemiain Vitro, Cellular Immunology, vol.189, issue.1, pp.41-50, 1998. ,
DOI : 10.1006/cimm.1998.1360
T and B cells in B-chronic lymphocytic leukaemia: Faust, Mephistopheles and the pact with the Devil, Cancer Immunology, Immunotherapy, vol.4, issue.2, pp.210-230, 2006. ,
DOI : 10.1007/s00262-005-0675-4
Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN, J Leukoc Biol, vol.72, pp.83-92, 2002. ,
B-Cell Lymphomas Differ in their Responsiveness to CpG Oligodeoxynucleotides, Clinical Cancer Research, vol.11, issue.4, pp.1490-1499, 2005. ,
DOI : 10.1158/1078-0432.CCR-04-1890
The Akt signaling pathway determines the different proliferative capacity of, pp.110-130, 2007. ,
Albumin activates the AKT signaling pathway and protects B-chronic lymphocytic leukemia cells from chlorambucil- and radiation-induced apoptosis, Blood, vol.101, issue.8, pp.3174-80, 2003. ,
DOI : 10.1182/blood-2002-07-2143
STAT5 Is Essential for Akt/p70S6 Kinase Activity during IL-2-Induced Lymphocyte Proliferation, The Journal of Immunology, vol.179, issue.8, pp.5301-5309, 2007. ,
DOI : 10.4049/jimmunol.179.8.5301
Regulation of Akt/PKB Ser473 Phosphorylation, Molecular Cell, vol.18, issue.2, pp.143-148, 2005. ,
DOI : 10.1016/j.molcel.2005.03.020
Constitutively activated phosphatidylinositol-3 kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cdelta IL-2, regulatory T cells, and tolerance, Blood Nelson, B.H. J Immunol, vol.100, issue.172, pp.3741-3749, 2002. ,
Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells, Journal of Experimental Medicine, vol.168, issue.1, pp.85-94, 1988. ,
DOI : 10.1084/jem.168.1.85
Leukemia-associated monoclonal and oligoclonal TCR-BV use in patients with B-cell chronic lymphocytic leukemia, Blood, vol.101, issue.3, pp.1063-70, 2003. ,
DOI : 10.1182/blood-2002-03-0746
Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine, Blood, vol.106, issue.6, pp.2018-2043, 2005. ,
DOI : 10.1182/blood-2005-02-0642
Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia, Blood, vol.97, issue.9, pp.2777-83, 2001. ,
DOI : 10.1182/blood.V97.9.2777
Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22, European Journal of Immunology, vol.32, issue.5, pp.1403-1416, 2002. ,
DOI : 10.1002/1521-4141(200205)32:5<1403::AID-IMMU1403>3.0.CO;2-Y
Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia, Blood, vol.86, pp.1115-1138, 1995. ,
Novel Insights in Chronic Lymphocytic Leukemia: Are We Getting Closer to Understanding the Pathogenesis of the Disease?, Journal of Clinical Oncology, vol.26, issue.27, pp.4497-503, 2008. ,
DOI : 10.1200/JCO.2007.15.4393
Mcl-1 expression has in vitro and in vivo significance in chronic lymphocytic leukemia and is associated with other poor prognostic markers, Blood, vol.112, issue.9, pp.3807-3824, 2008. ,
DOI : 10.1182/blood-2008-05-157131
miR-15 and miR-16 induce apoptosis by targeting BCL2, Proceedings of the National Academy of Sciences, vol.102, issue.39, pp.13944-13953, 2005. ,
DOI : 10.1073/pnas.0506654102
CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia, British Journal of Haematology, vol.101, issue.6, pp.721-753, 2007. ,
DOI : 10.1111/j.1365-2141.2007.06717.x
BCL2 family in DNA damage and cell cycle control, Cell Death and Differentiation, vol.62, issue.8, pp.1351-1360, 2006. ,
DOI : 10.1016/j.molcel.2004.12.030
Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity, Blood, vol.109, issue.4, pp.1660-1668, 2007. ,
DOI : 10.1182/blood-2006-05-021683
c-Abl kinase inhibitors overcome CD40-mediated drug resistance in CLL: implications for therapeutic targeting of chemoresistant niches, Blood, vol.112, issue.13, pp.5141-5150, 2008. ,
DOI : 10.1182/blood-2008-03-146704
Chronic lymphocytic leukemia microenvironment: shifting the balance from apoptosis to proliferation, Haematologica, vol.94, issue.6, pp.752-758, 2009. ,
DOI : 10.3324/haematol.2009.006676
Targeting PI3K signalling in cancer: opportunities, challenges and limitations, Nature Reviews Cancer, vol.16, issue.8, pp.550-62, 2009. ,
DOI : 10.1038/nrc2664